The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study
Matthew A Roberts, Helen L Pilmore, Francesco L Ierino, Sunil V Badve, Alan Cass, Amit X Garg, Carmel M Hawley, Nicole M Isbel, Henry Krum, Elaine M Pascoe, Andrew M Tonkin, Liza A Vergara, Vlado Perkovic
Nephrology | WILEY | Published : 2015
Related Projects (1)
Awarded by New Zealand Health Research Council Feasibility Study Grant
Awarded by National Health and Medical Research Council (NHMRC) Project Grant
Awarded by NHMRC Training Fellowship
The BLOCADE Feasibility Study acknowledges the following funding sources: Don & Lorraine Jacquot Collaborative Research Initiative Grant (2008), the New Zealand Health Research Council Feasibility Study Grant (10-163), the National Health and Medical Research Council (NHMRC) Project Grant (1006171) and Pfizer CVL (2008). Roche Products, Pty Limited provided Dilatrend(R) at a discounted price. In addition, MAR was supported by an NHMRC Training Fellowship (628902).